Todorović, S. (2023). RISK OF COVID-19 INFECTION IN PATIENTS WITH MULTIPLE SCLEROSIS TREATED WITH OCRELIZUMAB – A SINGLE CENTER EXPERIENCE. Acta Medicae Medianae, 62(3). https://asistent.ceon.rs/index.php/amm/article/view/41552